These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 30902748)

  • 1. Effect of water extract from Berberis heteropoda Schrenk roots on diarrhea-predominant irritable bowel syndrome by adjusting intestinal flora.
    Zhu HM; Li L; Li SY; Yan Q; Li F
    J Ethnopharmacol; 2019 Jun; 237():182-191. PubMed ID: 30902748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The antibacterial activity of Berberis heteropoda Schrenk and its effect on irritable bowel syndrome in rats.
    Li L; Zhu HM; Yan Q; Li SY; Li F
    Chin J Nat Med; 2020 May; 18(5):356-368. PubMed ID: 32451093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chang-Kang-Fang alleviates diarrhea predominant irritable bowel syndrome (IBS-D) through inhibiting TLR4/NF-κB/NLRP3 pathway.
    Zhang S; Tian D; Xia Z; Yang F; Chen Y; Yao Z; He Y; Miao X; Zhou G; Yao X; Tang J
    J Ethnopharmacol; 2024 Aug; 330():118236. PubMed ID: 38670405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of acupuncture and moxibustion on intestinal flora in the rats with diarrhea-predominant irritable bowel syndrome based on 16S rDNA technique.
    Lai BY; Hong MY; He YJ; Li X; Wang SS; Chen Y; Li XW; Nie J; Liu D; She C
    Zhongguo Zhen Jiu; 2023 Dec; 43(12):1411-1421. PubMed ID: 38092540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fecal bacteria can predict the efficacy of rifaximin in patients with diarrhea-predominant irritable bowel syndrome.
    Li Y; Hong G; Yang M; Li G; Jin Y; Xiong H; Qian W; Hou X
    Pharmacol Res; 2020 Sep; 159():104936. PubMed ID: 32470562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ginger relieves intestinal hypersensitivity of diarrhea predominant irritable bowel syndrome by inhibiting proinflammatory reaction.
    Zhang C; Huang Y; Li P; Chen X; Liu F; Hou Q
    BMC Complement Med Ther; 2020 Sep; 20(1):279. PubMed ID: 32928188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Momordica charantia polysaccharides alleviate diarrhea-predominant irritable bowel syndrome by regulating intestinal inflammation and barrier via NF-κB pathway.
    Ji S; Zhang Q
    Allergol Immunopathol (Madr); 2022; 50(3):62-70. PubMed ID: 35527657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Da-Jian-Zhong decoction alleviates diarrhea-predominant irritable bowel syndrome via modulation of gut microbiota and Th17/Treg balance.
    Zhang MM; Dang M; Wu X; Ou L; Li M; Zhao CB; Wei PF; Dong TW; Li Y; Wu CJ
    J Ethnopharmacol; 2024 Sep; 331():118275. PubMed ID: 38729534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fecal and Mucosa-Associated Intestinal Microbiota in Patients with Diarrhea-Predominant Irritable Bowel Syndrome.
    Maharshak N; Ringel Y; Katibian D; Lundqvist A; Sartor RB; Carroll IM; Ringel-Kulka T
    Dig Dis Sci; 2018 Jul; 63(7):1890-1899. PubMed ID: 29777439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of mild moxibustion on intestinal microbiota and NLRP6 inflammasome signaling in rats with post-inflammatory irritable bowel syndrome.
    Bao CH; Wang CY; Li GN; Yan YL; Wang D; Jin XM; Wu LY; Liu HR; Wang XM; Shi Z; Wu HG
    World J Gastroenterol; 2019 Aug; 25(32):4696-4714. PubMed ID: 31528095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of mucosal flora and enterochromaffin cells of the caecum and descending colon in diarrhoea-predominant irritable bowel syndrome.
    Yang J; Wang P; Liu T; Lin L; Li L; Kou G; Zhou R; Li P; Li Y
    BMC Microbiol; 2021 Nov; 21(1):316. PubMed ID: 34773967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Altered expression of L-type calcium channel alpha1C and alpha1D subunits in colon of rats with diarrhea-predominant irritable bowel syndrome].
    Zhu J; Luo HS; Chen L; Zhou T
    Zhonghua Yi Xue Za Zhi; 2009 Oct; 89(38):2713-7. PubMed ID: 20137275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of two laboratory model methods for diarrheal irritable bowel syndrome.
    Chen Q; Zhang H; Sun CY; He QY; Zhang RR; Luo BF; Zhou ZH; Chen XF
    Mol Med; 2023 Jan; 29(1):5. PubMed ID: 36635623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fecal Microbiota of Diarrhea-Predominant Irritable Bowel Syndrome Patients Causes Hepatic Inflammation of Germ-Free Rats and Berberine Reverses It Partially.
    Jia Q; Zhang L; Zhang J; Pei F; Zhu S; Sun Q; Duan L
    Biomed Res Int; 2019; 2019():4530203. PubMed ID: 31073525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Orally administered novel cyclic pentapeptide P-317 alleviates symptoms of diarrhoea-predominant irritable bowel syndrome.
    Zielińska M; Chen C; Mokrowiecka A; Cygankiewicz AI; Zakrzewski PK; Sałaga M; Małecka-Panas E; Wlaź P; Krajewska WM; Fichna J
    J Pharm Pharmacol; 2015 Feb; 67(2):244-54. PubMed ID: 25515402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Linderae Radix water extract treats diarrhea-predominant irritable bowel syndrome in rats: a serum metabolomics study].
    Liu T; Wu ML; Deng GY; He Y; He YR; Deng GM; Ouyang LQ
    Zhongguo Zhong Yao Za Zhi; 2023 Oct; 48(19):5356-5364. PubMed ID: 38114125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antinociceptive and antidiarrheal effects of pioglitazone in a rat model of diarrhoea-predominant irritable bowel syndrome: role of nitric oxide.
    Paragomi P; Rahimian R; Kazemi MH; Gharedaghi MH; Khalifeh-Soltani A; Azary S; Javidan AN; Moradi K; Sakuma S; Dehpour AR
    Clin Exp Pharmacol Physiol; 2014 Feb; 41(2):118-26. PubMed ID: 24471407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors.
    Lin H; Guo Q; Wen Z; Tan S; Chen J; Lin L; Chen P; He J; Wen J; Chen Y
    Microb Cell Fact; 2021 Dec; 20(1):233. PubMed ID: 34963452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Limited prolonged effects of rifaximin treatment on irritable bowel syndrome-related differences in the fecal microbiome and metabolome.
    Zeber-Lubecka N; Kulecka M; Ambrozkiewicz F; Paziewska A; Goryca K; Karczmarski J; Rubel T; Wojtowicz W; Mlynarz P; Marczak L; Tomecki R; Mikula M; Ostrowski J
    Gut Microbes; 2016 Sep; 7(5):397-413. PubMed ID: 27662586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. WenTongGanPi decoction alleviates diarrhea-predominant irritable bowel syndrome by improving intestinal barrier.
    Li Y; Chen Y; Liao Z; Liu Y; Liu C; Yang W; Bai J; Huang X; Hao Y; Liu S; Liu Y
    J Ethnopharmacol; 2024 Nov; 334():118544. PubMed ID: 39013542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.